Latest News

Genentech’s Susvimo receives new FDA indication for diabetic retinopathy
Genentech’s Susvimo receives new FDA indication for diabetic retinopathy

May 22nd 2025

Susvimo is the first and only FDA-approved, continuous delivery treatment shown to maintain vision in people with DR with just one refill every 9 months.

Researchers find Alzheimer disease detection potential in blood-based, retinal biomarkers
Researchers find Alzheimer disease detection potential in blood-based, retinal biomarkers

May 22nd 2025

Intalight's DREAM OCT platform receives CE Mark
Intalight's DREAM OCT platform receives CE Mark

May 21st 2025

AI systems demonstrate promising potential for DR screening, study finds
AI systems demonstrate promising potential for DR screening, study finds

May 20th 2025

Lineage to announce data from phase 1/2a study on use of RG6501
Lineage to announce data from phase 1/2a study on use of RG6501

May 20th 2025

Latest Videos

Latest News

© 2025 MJH Life Sciences

All rights reserved.